Old Web
English
Sign In
Acemap
>
authorDetail
>
Taku Yoshida
Taku Yoshida
Eisai
Molecular biology
Eribulin
Eribulin Mesylate
Epithelial–mesenchymal transition
Mesenchymal–epithelial transition
4
Papers
382
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
2017
Nature Chemical Biology
Taisuke Uehara
Yukinori Minoshima
Koji Sagane
Naoko Hata Sugi
Kaoru Ogawa Mitsuhashi
Noboru Yamamoto
Hiroshi Kamiyama
Kentaro Takahashi
Yoshihiko Kotake
Mai Uesugi
Akira Yokoi
Atsushi Inoue
Taku Yoshida
Miyuki Mabuchi
Akito Tanaka
Takashi Owa
Show All
Source
Cite
Save
Citations (176)
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
2014
British Journal of Cancer
Taku Yoshida
Yoichi Ozawa
Takayuki Kimura
Yoshiaki Sato
Galina Kuznetsov
Shanqin Xu
Mai Uesugi
Sergei Agoulnik
Noel Taylor
Yasuhiro Funahashi
Junji Matsui
Show All
Source
Cite
Save
Citations (204)
Abstract A296: Eribulin mesylate suppresses experimental metastasis in the MX-1 human breast cancer model by reversing phenotypic states between epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET).
2013
Molecular Cancer Therapeutics
Taku Yoshida
Galina Kuznetsov
Takayuki Kimura
Naoko Hata Sugi
Hajime Shimizu
Yoichi Ozawa
Yoshiaki Sato
Taisuke Uehara
Hideki Watanabe
Kentaro Takahashi
Kentaro Matsuura
Mai Uesugi
Osamu Toyama
Mamoru Yanagimachi
Yasuhiro Funahashi
Junji Matsui
Show All
Source
Cite
Save
Citations (2)
Procédé pour l'examen d'une action d'un agent anti-cancéreux utilisant un défaut d'épissage en tant que mesure
2008
Yoshiharu Mizui
Naoko Hata
Masao Iwata
Koji Sagane
Mai Uesugi
Tadashi Kadowaki
Taku Yoshida
Show All
Source
Cite
Save
Citations (0)
1